What science can do
Welcome to AstraZeneca Israel
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
AstraZeneca Israel was established at the end of 2008 and is based in Hod Hasharon, employing over 100 people, specializing in sales, marketing, medical & regulatory affairs. In addition AstraZeneca Israel has a strong presence of scientific research and development with partnerships across the country.
In May 2019 AstraZeneca signed a MOU (memorandum of understanding) with the Israeli innovation authority, committing to invest and support the Israeli healthcare ecosystem. AstraZeneca Israel is proud to be an active part of the AstraZeneca Health Innovation Hubs network alongside the US, China, Sweden, and France
At AstraZeneca Israel by following the science and doing the right thing, we reshape the reality, of our patients, our employees, and our payers.
AstraZeneca (Israel) Ltd.
P.O. Box 1455, 6 Hacharash St., Building E
Hod Hasharon 4524075 Israel
Tel: +972 9 740 6528
Fax: +972 9 740 6527
Our Therapy Areas
Summary of Product Characteristics (SPCs)
For information on AstraZeneca Israel’s products please click on the relevant Summary of Product Characteristic on the Ministry of Health website
If you have a further query on any AstraZeneca product please contact us.
Our Health Innovation Hub
The BeyondBio Health Innovation Hub in Israel is the fulfilment of the MOU (memorandum of understanding) that AstraZeneca signed with the Israeli Innovation authority in May 2019. AstraZeneca has committed to invest in research and digital innovation in Israel and to support the Israeli ecosystem.
As part of this commitment AstraZeneca has already launched two successful initiations and is looking forward to increasing its local presence.
During 2019-20 AstraZeneca Established two strategic partnerships:
- PlayBeyondBio – a start-up collaboration program in partnership with JVP, Yozma Leumit (II2020), Maccabi healthcare, Shaarei Zedek medical center, Microsoft and Cisco.
- ARC partnership with Sheba Medical Center.
AstraZeneca Israel is proud to be an active part of the AstraZeneca Health Innovation Hubs net alongside the US, China, Sweden, France and others.
Our sustainability ambition
To use our capabilities to make the most meaningful impact where society needs it – health
Join AstraZeneca Israel
Interested in advancing you career?
We turn good ideas into effective medicines that make a real difference for patients around the world. Good ideas depend on good people and we want to hire the best.
AstraZeneca Israel focuses on being a Great Place To Work, but this is not a goal for us, but a constant journey, that keeps challenging us to constantly improve and re-look at how we do things.
We would like the people who are joining us to be a part of that journey and have feel free and supported to bring new ideas to life and to develop their potential to the next level and be part of our global pool of career opportunities and growth.
AstraZeneca Israel is constantly growing and expanding in areas such as Sales, Marketing, Medical Information, Regulatory, Clinical Research and Administration. If you are interested in joining AstraZeneca Israel Ltd. Please send us a copy of your latest CV, to this link.
Potential candidates should be wary of approaches that appear to be offering a job for which they have not applied, especially if personal details or money must be sent in order to proceed with the recruitment. Neither AstraZeneca nor any commissioned third parties recruit in this manner. Such approaches are almost certainly fraudulent attempts to gain details of identity for illegal use.
Science compels us to push the boundaries of what is possible. We trust in the potential of ideas and pursue them, alone and with others, until we have transformed the treatment of disease.